Maat Pharma SA
PAR:MAAT
Maat Pharma SA
Other Current Assets
Maat Pharma SA
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
M
|
Maat Pharma SA
PAR:MAAT
|
Other Current Assets
€2.5m
|
CAGR 3-Years
94%
|
CAGR 5-Years
92%
|
CAGR 10-Years
N/A
|
|
Valneva SE
PAR:VLA
|
Other Current Assets
€58.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Innate Pharma SA
PAR:IPH
|
Other Current Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
G
|
Genfit SA
PAR:GNFT
|
Other Current Assets
€3.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-6%
|
|
Inventiva SA
PAR:IVA
|
Other Current Assets
€7m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
||
Eurobio Scientific SA
PAR:ALERS
|
Other Current Assets
€1.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
22%
|
CAGR 10-Years
5%
|
Maat Pharma SA
Glance View
Maat Pharma SA operates as a clinical-stage microbiome therapeutics company. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 43 full-time employees. The company went IPO on 2021-11-08. The firm specializes in the microbiome therapy that is aimed to treatment of Gut Microbiota alteration (Dysbiosis) using patient-specific biotherapeutics in patients with serious medical conditions. Its MaaT Microbiome Restoration Therapy (MMRB) discovery and analysis platform supports the evaluation of drug candidates, the determination of new disease targets and the identification of biomarkers for microbiome-related conditions.
See Also
What is Maat Pharma SA's Other Current Assets?
Other Current Assets
2.5m
EUR
Based on the financial report for Dec 31, 2023, Maat Pharma SA's Other Current Assets amounts to 2.5m EUR.
What is Maat Pharma SA's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
92%
Over the last year, the Other Current Assets growth was 18%. The average annual Other Current Assets growth rates for Maat Pharma SA have been 94% over the past three years , 92% over the past five years .